Why the study?
Does intravenous urapidil improve brachial arterial compliance in men with essential hypertension?
Does intravenous urapidil improve brachial arterial compliance in men with essential hypertension?
Decreased arterial compliance in essential hypertension is likely due to structural alterations rather than just elevated blood pressure or autonomic activation, as acute blood pressure lowering with urapidil did not improve compliance.
Answers are grounded in this paper and cite their sources.
Acute BP reduction fails to restore brachial compliance; supports structural alterations as primary driver in essential hypertension.
Central (six patients) and brachial (12 patients) haemodynamics were studied in men with sustained essential hypertension before and after intravenous administration of an alpha post-synaptic adrenergic blocking drug, urapidil. Brachial arterial compliance was evaluated non-invasively from the simultaneous measurement of pulse wave velocity and arterial diameter. In basal conditions, arterial compliance was reduced in hypertensives. Urapidil caused a significant drop in blood pressure, due to a significant decrease in total peripheral resistance with no change in cardiac output and heart rate. Brachial arterial diameter and compliance did not change significantly. The results show that the decreased arterial compliance in hypertensive patients was not due exclusively to the elevation of blood pressure or to a predominant activation of the autonomic nervous system, or both. Such observations suggest that, in men with sustained essential hypertension, the decreased compliance was probably related to structural alterations of large arteries.
No takes yet. Share an insight, caveat, or question.
Levenson et al. (1984) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: